Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $8.3 million ...

Amazon challenges Perplexity's AI shopping tool, citing legality and customer experience concerns. Learn more about AI, ...

OPEC+’s efforts to calm fears of a 2026 oil glut failed to move crude prices, which remain flat near $65 per barrel amid ...

You can create a PivotTable in Excel from an external data source, a table in your worksheet, or a pre-built data model. To ...

Google Photos is testing new AI-powered tools, including an Ask Photos button for easier memory searches and an Outfits collection feature.

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 ...

Matt Swain has become a pioneer by pairing family offices looking to triple their money with under-the-radar businesses ...

HE is on a mission to help our pets  . . . and is here to answer YOUR questions. Sean, who is the head vet at tailored pet food firm tails.com, has helped with owners’ queries for ten years. He ...

Discover why T-Mobile is undervalued and positioned for growth with AI-driven demand. Read my analysis of TMUS stock here.

Today’s AI technology has unlocked the possibility of universal access to professional-grade patent intelligence.

The company sees no supply constraints for tirzepatide, a concern that has plagued other players in the GLP-1 space globally.